Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 12,556	$ 13,154	$ 26,101	$ 27,907
General and administrative	9,574	6,878	16,275	13,686
Total operating expenses	22,130	20,032	42,376	41,593
Loss from operations	(22,130)	(20,032)	(42,376)	(41,593)
Other income (expense):
Interest income	464	539	1,101	1,161
Other income (expense)	1,757	341	3,141	405
Total other income (expense), net	2,221	880	4,242	1,566
Net loss	$ (19,909)	$ (19,152)	$ (38,134)	$ (40,027)
Net loss per share, basic (in dollars per share)	$ (0.36)	$ (0.52)	$ (0.71)	$ (1.09)
Net loss per share, diluted (in dollars per share)	$ (0.36)	$ (0.52)	$ (0.71)	$ (1.09)
Weighted average common shares outstanding, basic (in shares)	55,155,220	36,516,114	53,482,034	36,500,085
Weighted average common shares outstanding, diluted (in shares)	55,155,220	36,516,114	53,482,034	36,500,085
Comprehensive loss:
Net loss	$ (19,909)	$ (19,152)	$ (38,134)	$ (40,027)
Other comprehensive income (loss):
Unrealized gain (loss) on investments, net	(20)	515	(88)	1,163
Comprehensive loss	$ (19,929)	$ (18,637)	$ (38,222)	$ (38,864)